Enzymes: Biomarkers, Targets and Therapy examines the critical role of enzymes in drug discovery, diagnostics, and therapeutic applications, providing essential insights for clinicians, biomedical researchers, and pharmaceutical industry professionals. This book highlights the utility of enzymes as biomarkers for disease diagnosis, targets for innovative drug discovery, and therapeutic agents in treating various conditions. Within its comprehensive chapters, the book discusses enzymatic biomarkers in neurodegenerative disorders such as Alzheimer's disease and ?-synucleinopathies, where enzymes are pivotal in understanding disease mechanisms and potential interventions.It covers enzymatic drug targets in cancers and diabetes, offering insights into harnessing enzymes for novel therapeutic strategies. Additionally, the book explores the role of enzymes in lipid and hypertensive disorders, emphasizing their potential in managing these conditions. Further, the book examines enzymes as therapeutic agents in autoimmune and infectious diseases, featuring approaches like CRISPR-Cas9 gene editing to tackle antimicrobial resistance. By providing curated information, this book equips its audience with the necessary knowledge to explore new directions in drug discovery and enzymatic therapy.Explains the role of enzymes as biomarkers in disease diagnosis, providing clinicians with essential insights for improved diagnostic strategiesDiscusses enzymes as targets for drug discovery, offering biomedical researchers valuable information for advancing therapeutic developmentEvaluates the use of enzymes as therapeutic molecules, guiding pharmaceutical industry researchers in developing enzyme-based treatments

Enzymes: Biomarkers, Targets and Therapy examines the critical role of enzymes in drug discovery, diagnostics, and therapeutic applications, providing essential insights for clinicians, biomedical researchers, and pharmaceutical industry professionals. This book highlights the utility of enzymes as biomarkers for disease diagnosis, targets for innovative drug discovery, and therapeutic agents in treating various conditions. Within its comprehensive chapters, the book discusses enzymatic biomarkers in neurodegenerative disorders such as Alzheimer's disease and ?-synucleinopathies, where enzymes are pivotal in understanding disease mechanisms and potential interventions.It covers enzymatic drug targets in cancers and diabetes, offering insights into harnessing enzymes for novel therapeutic strategies. Additionally, the book explores the role of enzymes in lipid and hypertensive disorders, emphasizing their potential in managing these conditions. Further, the book examines enzymes as therapeutic agents in autoimmune and infectious diseases, featuring approaches like CRISPR-Cas9 gene editing to tackle antimicrobial resistance. By providing curated information, this book equips its audience with the necessary knowledge to explore new directions in drug discovery and enzymatic therapy.Explains the role of enzymes as biomarkers in disease diagnosis, providing clinicians with essential insights for improved diagnostic strategiesDiscusses enzymes as targets for drug discovery, offering biomedical researchers valuable information for advancing therapeutic developmentEvaluates the use of enzymes as therapeutic molecules, guiding pharmaceutical industry researchers in developing enzyme-based treatments